Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development
Purpose: We previously confirmed its anti-atherosclerotic effects by pre-treatment with compound-326, a selective delta-5 desaturase (D5D) inhibitor, in Western diet-fed ApoE knockout mice. In the present study, we evaluated effects of compound-326 in ApoE knockout mice with two different protocols...
Saved in:
Main Authors: | Hiroki Nagase (Author), Shuichi Takagahara (Author), Yoshinori Satomi (Author), Ayumi Ando (Author), Kazuki Kubo (Author), Shota Ikeda (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
by: Zuo Q, et al.
Published: (2022) -
Inulin alleviates atherosclerosis through improving lipid metabolism, inflammation, and gut microbiota in ApoE-knockout mice: the short-chain is more efficacious
by: Kun Zhang, et al.
Published: (2024) -
EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation
by: Lizhi Pang, et al.
Published: (2020) -
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015) -
Genetic disruption of the Gipr in Apoe−/− mice promotes atherosclerosis
by: Gemma Pujadas, et al.
Published: (2022)